Gujarat Themis Biosyn Ltd.

GUJ.THEMIS.

Market Cap
₹2,795 Cr.
P/E
50.85

Gujarat Themis Biosyn Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Unable to calculate due to limited data
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years but more due to rerating
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
38.87%
3yr Average
41.41%
5yr Average
42.99%
Net Profit Margin
Latest
38.91%
3yr Average
36.74%
5yr Average
30.73%
ROCE
Latest
51.42%
3yr Average
55.34%
5yr Average
55.35%
Debt to Equity
Latest
-
3yr Average
0.01
5yr Average
0.11
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Peer Comparison
Company Filing
Show Previous Years
Discussions & Analysis
Gujarat Themis Biosyn Ltd.
View the discussion on ValuePickr
Gujarat Themis Biosyn Ltd Analysis - Alphaspot
Quick look at Gujarat Themys - Smart Sync Services
Interview With Dr Sachin Patel, CEO, Themis Medicare and Gujarat Themis Biosyn - Sensei Kujaku
timeline